Shandong Lukang Pharmaceutical Co.,Ltd.’s Net Profit Dropped 4.3% in First Half of 2022

Shandong Lukang Pharmaceutical Co.,Ltd. (山东鲁抗医药股份有限公司) (600789.SH) reported a net profit of 69.3 million yuan in the first half of 2022, down 4.3% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, up 11.4% year-on-year.

At the end of the reporting period, it had 8.3 billion yuan in total assets and 4.8 billion yuan in total liabilities, with a liability-to-asset ratio of 57.9%.